Cryo Cell International (CCEL) Treasury Shares (2010 - 2026)

Cryo Cell International (CCEL) has reported Treasury Shares for 17 consecutive years, with $25.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Treasury Shares rose 28138.93% year-over-year to $25.0 million; the TTM figure through May 2026 stood at $25.0 million (up 28138.93% YoY), while the FY2025 annual figure was $25.0 million, up 1657.54% from the prior year.
• Treasury Shares steadied at $25.0 million in Q2 2026 per CCEL's latest filing, from $25.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $6.8 million in Q3 2025 and bottomed at $6.2 million in Q1 2022.
• Historically, Treasury Shares has averaged $6.6 million across 5 years, with a median of $6.7 million in 2024.
• Annual changes were most pronounced in 2022 — Treasury Shares plunged 98.7% — and 2025, when it soared 152491.82%.
• Cryo Cell International's Treasury Shares stood at $22.6 million in 2022, then rose by 3.53% to $23.4 million in 2023, then plunged by 93.92% to $1.4 million in 2024, then surged by 1657.54% to $25.0 million in 2025, then changed by 0.0% to $25.0 million in 2026.
• Business Quant data shows CCEL's Treasury Shares at $25.0 million in Q2 2026, $25.0 million in Q1 2026, and $25.0 million in Q4 2025.